The Brucella & Diagnostics Section focuses on the production of vaccines and diagnostic reagents for the detection and prevention of Brucellosis — a zoonotic disease affecting cattle, goats, and humans. The section operates under biosafety level-3 (BSL-3) containment to ensure safe handling of pathogenic organisms.
The division also develops and supplies high-quality diagnostic kits, including antigens and test reagents used for serological screening of animal diseases.
The section operates under advanced biosafety infrastructure featuring:
The R&D team continuously works on improving vaccine safety profiles, antigenic stability, and developing advanced diagnostic assays such as ELISA and lateral flow kits. Collaborations with national reference laboratories enhance validation and field-level performance studies.
Every vaccine and diagnostic reagent is subjected to safety, sterility, and potency tests as per national veterinary biological standards. The section operates under strict QA-QC supervision, ensuring reliability and traceability of each batch.